The store will not work correctly when cookies are disabled.
N,N-dimethyl-2-(6-(2-(trifluoromethyl)pyridin-4-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide
ID: ALA4513602
PubChem CID: 124176296
Max Phase: Preclinical
Molecular Formula: C17H15F3N4O
Molecular Weight: 348.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)C(=O)Cn1ccc2ncc(-c3ccnc(C(F)(F)F)c3)cc21
Standard InChI: InChI=1S/C17H15F3N4O/c1-23(2)16(25)10-24-6-4-13-14(24)7-12(9-22-13)11-3-5-21-15(8-11)17(18,19)20/h3-9H,10H2,1-2H3
Standard InChI Key: JQVFAYKTLPONJV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
22.9006 -1.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8994 -2.7552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6075 -3.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6057 -1.5268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3143 -1.9320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3191 -2.7506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0991 -2.9991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5765 -2.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0914 -1.6746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3562 -3.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1565 -3.9401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4135 -4.7158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6997 -3.3296 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8702 -5.3262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2138 -4.8810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1914 -3.1632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4856 -2.7526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7781 -3.1600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7770 -3.9780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4893 -4.3870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1940 -3.9773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4916 -5.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7850 -5.6148 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.2004 -5.6109 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.4864 -6.0175 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 15 1 0
2 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 348.33 | Molecular Weight (Monoisotopic): 348.1198 | AlogP: 3.21 | #Rotatable Bonds: 3 |
Polar Surface Area: 51.02 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.31 | CX LogP: 2.28 | CX LogD: 2.28 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.73 | Np Likeness Score: -1.64 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |